Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Jan Molenaar

Group leader
Prof. dr. Jan Molenaar leads a research group in the Princess Máxima Center, which focuses on precision medicine in pediatric cancer.
Phone +31 6 18051678
  • Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM

    • dec. 2025
    • Elke, Pfaff, et al
    • Acta Neuropathologica
  • Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition

    • dec. 2025
    • Femke C.A.S., Ringnalda, et al
    • Nature communications
  • γδ T cells are the prime antitumoral T cells in pediatric neuroblastoma

    • nov. 2025
    • Suzanne M., Castenmiller, et al
    • Life science alliance
  • The immune landscape of pediatric (extra)cranial solid tumors

    • okt. 2025
    • Francisca J., Bergsma, et al
    • European Journal of Cancer
  • Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression

    • okt. 2025
    • Jelena, Milosevic, et al
    • Cancer letters
View all publications